Epidemiology of cervical cancer in Colombia

被引:1
|
作者
Munoz, Nubia [1 ]
Eduardo Bravo, Luis [2 ]
机构
[1] Inst Nacl Cancerol, Bogota, Colombia
[2] Registro Poblac Canc Cali, Cali, Colombia
来源
SALUD PUBLICA DE MEXICO | 2014年 / 56卷 / 05期
关键词
cervical cancer; incidence; mortality; spatio-temporal analysis; survival; HPV; prevention; vaccines; straining; Colombia; HUMAN-PAPILLOMAVIRUS; SCREENING-PROGRAMS; LATIN-AMERICA; PREVENTION; VACCINE; TRENDS; DNA;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective.To describe the incidence, mortality,time trends and prognostic factors for cervical cancer in Cali, Colombia, and to review the molecular epidemiological evidence showing that HPV is the major and necessary cause of cervical cancer and the implications of this discovery for primary and secondary prevention. Materials and methods. Incidence rates of cervical cancer during a 45-year period (1962-2007) were estimated based on the population-based cancer registry of Cali and the mortality statistics from the Municipal Health Secretariat of Cali. Prognostic factors were estimated based on relative survival. Review of the molecular epidemiological evidence linking HPV to cervical cancer was focused on the studies carried out in Cali and in other countries. Results. Incidence rates of squamous cell carcinoma (SCC) declined from 120.4 per 100 000 in 1962-1966 to 25.7 in 2003-2007 while those of adenocarcinoma increased from 4.2 to 5.8. Mortality rates for cervical cancer declined from 18.5 in 1984-1988 to 7.0 per 100 000 in 2009-2011. Survival was lower in women over 65 years of age and in clinical stages 3-4. Review of the molecular epidemiological evidence showed that certain types of HPV are the central and necessary cause of cervical cancer. Conclusions. A decline in the incidence and mortality of SCC and an increase in the incidence of adenocarcinoma during a 45-year period was documented in Cali, Colombia.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
  • [31] Human Papillomavirus, Current Vaccines, and Cervical Cancer Prevention
    Teitelman, Anne M.
    Stringer, Marilyn
    Averbuch, Tali
    Witkoski, Amy
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2009, 38 (01): : 69 - 80
  • [32] Sociodemographic characteristics and their association with survival in women with cervical cancer
    Cetina-Perez, Lucely
    Luvian-Morales, Julissa
    Delgadillo-Gonzalez, Merari
    Castro-Eguiluz, Denisse
    Galicia-Carmona, Tatiana
    Rely, Kely
    Vaca Gonzalez, Rita
    Lugo-Martinez, Gabriela
    Garcia-Barrientos, Nadia
    Nateras, Antonio
    BMC CANCER, 2024, 24 (01)
  • [33] Cervical Cancer: A Review of Epidemiology, Treatments and Anticancer Drugs
    Babakanrad, Elmira
    Mohammadian, Taher
    Esmaeili, Davoud
    Behzadi, Payam
    CURRENT CANCER THERAPY REVIEWS, 2023, 19 (03) : 198 - 212
  • [34] Female genital schistosomiasis, human papilloma virus infection, and cervical cancer in rural Madagascar: a cross sectional study
    Kutz, Jean-Marc
    Rausche, Pia
    Rasamoelina, Tahinamandranto
    Ratefiarisoa, Sonya
    Razafindrakoto, Ravo
    Klein, Philipp
    Jaeger, Anna
    Rakotomalala, Rivo Solotiana
    Rakotomalala, Zoly
    Randrianasolo, Bodo Sahondra
    McKay-Chopin, Sandrine
    May, Juergen
    Rakotozandrindrainy, Rapahel
    Puradiredja, Dewi Ismajani
    Sicuri, Elisa
    Hampl, Monika
    Lorenz, Eva
    Gheit, Tarik
    Rakotoarivelo, Rivo Andry
    Fusco, Daniela
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [35] Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women
    Perehudoff, Katrina
    Vermandere, Heleen
    Williams, Alex
    Bautista-Arredondo, Sergio
    De Paepe, Elien
    Dias, Sonia
    Gama, Ana
    Keygnaert, Ines
    Longatto-Filho, Adhemar
    Ortiz, Jose
    Padalko, Elizaveta
    Reis, Rui Manuel
    Vanderheijden, Nathalie
    Vega, Bernardo
    Verberckmoes, Bo
    Degomme, Olivier
    BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS, 2020, 20 (01)
  • [36] HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
    Flores, Yvonne N.
    Bishai, David M.
    Lorincz, Attila
    Shah, Keerti V.
    Lazcano-Ponce, Eduardo
    Hernandez, Mauricio
    Granados-Garcia, Victor
    Perez, Ruth
    Salmeron, Jorge
    CANCER CAUSES & CONTROL, 2011, 22 (02) : 261 - 272
  • [37] Secular trends of HPV genotypes in invasive cervical cancer in Cali, Colombia 1950-1999
    Ines Sanchez, Gloria
    Eduardo Bravo, Luis
    Hernandez-Suarez, Gustavo
    Tous, Sara
    Alemany, Laia
    de Sanjose, Silvia
    Xavier Bosch, F.
    Munoz, Nubia
    CANCER EPIDEMIOLOGY, 2016, 40 : 173 - 178
  • [38] Re-emergence of educational inequalities in cervical cancer mortality, Colombia 1998-2015
    de Vries, Esther
    Arroyave, Ivan
    Pardo, Constanza
    JOURNAL OF CANCER POLICY, 2018, 15 : 37 - 44
  • [39] Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis
    Hernandez Vargas, Juliana Alexandra
    Ramirez Barbosa, Paula Ximena
    Gil Quijano, Ana Milena
    Maria Valbuena, Ana
    Acuna, Lizbeth
    Alberto Gonzalez, Jaime
    BMC CANCER, 2020, 20 (01)
  • [40] Epidemiology and survival of cervical cancer in Iran based on national cancer registry data (2008-2014)
    Akbari, Atieh
    Khayamzadeh, Maryam
    Salmanian, Reza
    Moradi, Afshin
    Akbari, Mohammad Esmaeil
    FRONTIERS IN ONCOLOGY, 2023, 13